The syntheses and the solid state structural and spectroscopic solution cha
racterizations of VO(Me-acac)(2) and VO(Et-acac)(2) (where Me-acac is 3-met
hyl-2,4-pentanedionato and Et-acac is 3-ethyl-2,4-pentanedionato) have been
conducted since both VO(acac)(2) and VO(Et-acac)(2) have long-term in vivo
insulin-mimetic effects in streptozotocin-induced diabetic Wistar rats. X-
ray structural characterizations of VO(Me-acac)(2) and VO(Et-acac)(2) show
that both contain five-coordinate vanadium similar to the parent VO(acac)(2
). The unit cells for VO(Et-acac)(2) and VO(Me-acac)(2) are both triclinic,
P (1) over bar, with a 9.29970(10) Angstrom, b = 13.6117(2) Angstrom, c 13
.6642(2) Angstrom, alpha = 94.1770(10)degrees,beta = 106.4770(10)degrees, g
amma = 106.6350(10)degrees for VO(Et-acac)(2) and a = 7.72969(4) Angstrom,
b = 8.1856(5) Angstrom, 11.9029(6) Angstrom, alpha = 79.927(2)degrees, beta
= 73.988(2)degrees, gamma = 65.1790(10)degrees For VO(Me-acac)(2). The tot
al concentration of EPR-observable vanadium(IV) species for VO(acac)(2) and
derivatives in water solution at 20 degrees C was determined by double int
egration of the EPR spectra and apportioned between individual species on t
he basis of computer simulations of the spectra. Three species were observe
d, and the concentrations were found to be time, pH, temperature, and salt
dependent. The three complexes are assigned as the trans-VO(acac)(2). H2O a
dduct, cis-VO-(acac)(2). H2O adduct, and a hydrolysis product containing on
e vanadium atom and one R-acac(-) group. The reaction rate for conversion o
f species was slower for VO(acac)(2) than for VO(malto)(2), VO(Et-acac)(2),
and VO(Me-acac)(2); however, in aqueous solution the rates for all of thes
e species are slow compared to those of other vanadium species. The concent
ration of vanadium(V) species was determined by V-51 NMR, The visible spect
ra were time dependent, consistent with the changes in species concentratio
ns that were observed in the EPR and NMR spectra. EPR and visible spectrosc
opic studies of solutions prepared as for administration to diabetic rats d
ocumented both a salt effect on speciation and formation of a new halogen-c
ontaining complex. Compound efficacy with respect to long-term lowering of
plasma glucose levels in diabetic rats traces the concentration of the hydr
olysis product in the administration solution.